Contribution of sialic acids to integrin α5β1 functioning in melanoma cells

Varki, 2007, Glycan-based interaction involving vertebrate sialic-acid-recognizing proteins, Nature, 446, 1023, 10.1038/nature05816 Croci, 2014, Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference, Oncoimmunology, 25 Croci, 2014, Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors, Cell, 156, 744, 10.1016/j.cell.2014.01.043 Nigam, 2006, Sialic acid in cardiovascular diseases, Indian J Clin Biochem, 21, 54, 10.1007/BF02913067 Wielgat, 2012, Significance of the cell adhesion molecules and sialic acid in neurodegeneration, Adv Med Sci, 57, 23, 10.2478/v10039-012-0011-0 Gińdzieńska-Sieśkiewicz, 2016, Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate, Adv Med Sci, 61, 193, 10.1016/j.advms.2015.12.009 Mahajan, 2016, Sialic acids and autoimmune disease, Immunol Rev, 269, 145, 10.1111/imr.12344 Julien, 2006, ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity, Glycobiology, 16, 54, 10.1093/glycob/cwj033 Varki, 2007, Diversity in cell surface sialic acid presentations: implications for biology and disease, Lab Invest, 87, 851, 10.1038/labinvest.3700656 Bauer, 2015, Sialic acids in biological and therapeutic processes: opportunities and challenges, Future Med Chem, 7, 2285, 10.4155/fmc.15.135 Lu, 2015, Significance of β-Galactoside α2,6 Sialyltranferase 1 in cancers, Molecules, 20, 7509, 10.3390/molecules20057509 Cagnoni, 2016, Turning-off signaling by siglecs, selectins, and galectins: chemical inhibition of glycan-dependent interactions in cancer, Front Oncol, 6, 109, 10.3389/fonc.2016.00109 Pearce, 2016, Sialic acids in cancer biology and immunity, Glycobiology, 26, 111, 10.1093/glycob/cwv097 Vajaria, 2016, Sialylation: an avenue to target cancer cells, Pathol Oncol Res, 22, 443, 10.1007/s12253-015-0033-6 Garbe, 2009, Melanoma epidemiology and trends, Clin Dermatol, 27, 3, 10.1016/j.clindermatol.2008.09.001 Erdmann, 2013, International trends in the incidence of malignant melanoma 1953‐2008 - are recent generations at higher of lower risk?, Int J Cancer, 132, 385, 10.1002/ijc.27616 Stadler, 2015, New therapeutic options for advanced non-resectable malignant melanoma, Adv Med Sci, 60, 83, 10.1016/j.advms.2014.12.002 Li, 2000, Dynamics of intercellular communication during melanoma development, Mol Med Today, 6, 163, 10.1016/S1357-4310(00)01692-0 Link-Lenczowski, 2011, Glycans in melanoma screening. Part 2. Towards the understanding of integrin N-glycosylation in melanoma, Biochem Soc Trans, 39, 374, 10.1042/BST0390374 Pocheć, 2016, Glycosylation of integrins in melanoma progression Hoja-Łukowicz, 2017, On the trail of the glycan codes stored in cancer-related cell adhesion proteins, Biochim Biophys Acta, 1861, 3237, 10.1016/j.bbagen.2016.08.007 Passaniti, 1988, Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative number of specific penultimate oligosaccharide structures, J Biol Chem, 263, 7591, 10.1016/S0021-9258(18)68540-0 Gorelik, 1995, Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferasegene expression, Melanoma Res, 55, 4168 Lityńska, 2001, Comparison of the lectin-binding pattern in different human melanoma cell lines, Melanoma Res, 11, 205, 10.1097/00008390-200106000-00001 Kolasińska, 2016, Towards understanding the role of sialylation in melanoma progression, Acta Biochim Pol, 63, 533, 10.18388/abp.2015_1221 Przybyło, 2016, Bitter sweetness of malignant melanoma: deciphering the role of cell surface glycosylation in tumour progression and metastasis Saldova, 2011, Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia, Glycobiology, 21, 195, 10.1093/glycob/cwq147 Wang, 2009, High expression of alpha 2, 3-linked sialic acid residues is associated with the metastatic potential of human gastric cancer, Cancer Detect Prev, 32, 437, 10.1016/j.cdp.2009.01.001 Shah, 2008, Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis, Glycoconj J, 25, 279, 10.1007/s10719-007-9086-4 Westermark, 1986, Human melanoma cell lines of primary and metastatic origin express the gene encoding the chains of platelet-derived growth factor (PDGF) and produce PDGF-like growth factor, Proc Natl Acad Sci USA, 83, 7197, 10.1073/pnas.83.19.7197 Peterson, 1977, A simplification of the protein assay method of Lowry et al. Which is more generally applicable, Anal Biochem, 83, 346, 10.1016/0003-2697(77)90043-4 Wobbe, 2006, Integrin alpha 5 beta 1: a new purification strategy based on immobilised peptides, J Peptide Res, 66, 22, 10.1111/j.1747-0285.2006.00359.x Markwell, 1980, Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants, Proc Natl Acad Sci U S A, 77, 5693, 10.1073/pnas.77.10.5693 Pocheć, 2003, Glycosylation profile of integrin alpha 3 beta 1 changes with melanoma progression, Biochim Biophys Acta, 1643, 113, 10.1016/j.bbamcr.2003.10.004 Bellis, 2004, Variant glycosylation: an underappreciated regulatory mechanism for β1 integrins, Biochim Biophys Acta Biomembr, 1663, 52, 10.1016/j.bbamem.2004.03.012 Schultz, 2012, Regulation of the metastatic cell phenotype by sialylated glycans, Cancer Metastasis Rev, 31, 501, 10.1007/s10555-012-9359-7 Büll, 2014, Sialic acids sweeten a tumour’s life, Cancer Res, 74, 3199, 10.1158/0008-5472.CAN-14-0728 Dall’Olio, 2014, Sialosignaling: sialyltransferasea as engines of self-fueling loops in cancer progression, Biochim Biophys Acta, 1840, 2752, 10.1016/j.bbagen.2014.06.006 Gomes, 2013, Expression of ST3GAL4 leads to SL(x) expression and induces c-Met activation and invasive phenotype in gastric carcinoma cells, PLoS One, 8, 10.1371/journal.pone.0066737 Cui, 2011, Differential expression of the α2,3-sialic acid residues in breast cancer is associated with metastatic potential, Oncol Rep, 25, 1365 Chen, 2011, A novel sialyltransferase inhibitor suppresses FAK/paxillin signalling and cancer angiogenesis and metastatic pathways, Cancer Res, 71, 473, 10.1158/0008-5472.CAN-10-1303 Chovanec, 2004, Comparative analysis of α2,3/2,6-linked N-acetyneuraminic acid and cytokeratin expression in head and neck squamous cell carcinoma, Oncol Rep, 12, 297 Anderson, 2014, Structural and mechanical function of integrins, Biophys Res, 6, 203 Pan, 2016, Research advances on structure and biological functions of integrins, Springerplus, 5, 1094, 10.1186/s40064-016-2502-0 Streuli, 2009, Signal co-operation between integrins and other receptor systems, Biochem J, 418, 491, 10.1042/BJ20081948 Alam, 2007, The integrin-growth factor receptor duet, J Cell Physiol, 213, 649, 10.1002/jcp.21278 Gu, 2004, Regulation of integrin functions by N-glycans, Glycoconj J, 21, 9, 10.1023/B:GLYC.0000043741.47559.30 Yu, 2013, Caveolin-1 up-regulates integrin α2,6-sialylation to promote integrin α5β1-dependent hepatocarcinoma cell adhesion, FEBS Lett, 587, 782, 10.1016/j.febslet.2013.02.002 Zhou, 2000, Over expression of integrin α5β1 in human hepatocellular carcinoma cell line suppress cell proliferation in vitro and tumorigenicity in nude mice, Mol Cell Biochem, 207, 49, 10.1023/A:1007034012642 Samandari, 2006, The effect of γ-tocopherol on proliferation, integrin expression, adhesion, and migration of human glioma cells, Biochem Biophys Res Commun, 342, 1329, 10.1016/j.bbrc.2006.02.110 Wang, 2011, Integrin subunit α5 and α6 regulate cell cycle by modulating the chk1 and Rb/E2F to affect breast cancer metastasis, Mol Cancer, 10, 84, 10.1186/1476-4598-10-84 Quian, 2005, Interaction between integrin α5 and fibronectin is required for metastasis of B16F10 melanoma cells, Biochem Biophys Res Commun, 333, 1269, 10.1016/j.bbrc.2005.06.039 Li, 2017, Conformational equilibria and intrinsic affinities define integrin activation, EMBO J, 36, 629, 10.15252/embj.201695803 Hang, 2017, A key regulator of cell adhesion: identification and characterization of important N-glycosylation sites on integrin α5 for cell migration, Mol Cell Biol, 37, e00558, 10.1128/MCB.00558-16 Hang, 2015, Integrin α5 supresses the phosphorylation of epidermal growth factor receptor and its cellular signaling of cell proliferation via N-glycosylation, J Biol Chem, 200, 29345, 10.1074/jbc.M115.682229 Hang, 2016, N-glycosylation of integrin α5 acts as a swich for EGFR-mediated complex formation of integrin α5β1 and α6β4, Sci Rep, 6, 33507, 10.1038/srep33507 Janik, 2010, Cell migration-the role of integrin glycosylation, Biochim Biophys Acta, 1800, 545, 10.1016/j.bbagen.2010.03.013 Takahashi, 2016, Disease-associated glycans on cell surface proteins, Mol Asp Med, 51, 56, 10.1016/j.mam.2016.04.008 Pretzlaff, 2000, Sialidase treatment exposes the beta1-integrin active ligand binding site on HL60 cells and increases binding to fibronectin, Cell Adhes Commun, 7, 491, 10.3109/15419060009040306 Semel, 2002, Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors, J Biol Chem, 277, 32830, 10.1074/jbc.M202493200 Ono, 2000, Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional α3, α5-CD82 glycosylation complex in ldlD 14 cells, Biochem Biophys Res Commun, 279, 744, 10.1006/bbrc.2000.4030 Nadanaka, 2001, Occurrence of oligosialic acids on integrin α5 subunit and their involvement in cell adhesion to fibronectin, J Biol Chem, 276, 33657, 10.1074/jbc.M011100200 Yuan, 2016, Effect of alpha 2,6 sialylation on integrin-mediated adhesion of breast cancer cells to fibronectin and collagen IV, Life Sci, 149, 138, 10.1016/j.lfs.2016.02.071